Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.M. Rangwala, M.A. Lazar.
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
Trends Pharmacol Sci, 25 (2004), pp. 331-336
[2.]
D. Einhorn, V.R. Aroda, R.R. Henry.
Glitazones and the management of insulin resistance: what they do and how might they be used.
Endocrinol Metab Clin North Am, 33 (2004), pp. 595-616
[3.]
F. Villarroya, R. Iglesias, M. Giralt.
Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes.
Curr Med Chem, 11 (2004), pp. 795-805
[4.]
C.F. Deacon.
Therapeutic strategies based on glucagon-like peptide 1.
Diabetes, 53 (2004), pp. 2181-2189
[5.]
I. Valverde.
El GLP-1, incretina antidiabética con potencial terapéutico.
Av Diabetol, 17 (2001), pp. 191-198
[6.]
I. Valverde, M.L. Villanueva-Penacarrillo.
In vitro insulinomimetic effects of GLP-1 in liver, muscle and fat.
Acta Physiol Scand, 157 (1996), pp. 359-360
[7.]
I. Valverde, M.L. Villanueva-Penacarrillo, W.J. Malaisse.
Pancreatic and extrapancreatic effects of GLP-1.
Diabetes Metab, 28 (2002),
[8.]
M.L. Villanueva-Peñacarrillo, J. Puente, A. Redondo, F. Clemente, I. Valverde.
Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
Endocrine, 15 (2001), pp. 241-248
[9.]
M.A. Luque, N. González, L. Márquez, A. Acitores, A. Redondo, M. Morales, I. Valverde, M.L. Villanueva-Peñacarrillo.
GLP-1 and glucose metabolism in human myocytes.
J Endocrinol, 173 (2002), pp. 465-473
[10.]
A. Redondo, V. Trigo, A. Acitores, I. Valverde, M.L. Villanueva-Peñacarrillo.
Cell signalling of the GLP-1 action in rat liver.
Mol Cell Endocrinol, 204 (2003), pp. 43-50
[11.]
A. Acitores, N. González, V. Sancho, I. Valverde, M.L. Villanueva-Peñacarrillo.
Cell signalling of the glucagon like peptide-1 action in rat skeletal muscle.
J Endocrinol, 180 (2004), pp. 389-398
[12.]
J.J. Meier, M.A. Nauck.
The potential role of glucagon-like peptide 1 in diabetes.
Curr Opin Investig Drugs, 5 (2004), pp. 402-410
[13.]
G.G. Holz, O.G. Chepurny.
Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.
Curr Med Chem, 10 (2003), pp. 2471-2483
Copyright © 2005. Sociedad Española de Endocrinología y Nutrición